Will the Supreme Court rule on gene patents?
12 December 2011
|
Eileen McDermott, New York
The Association for Molecular Pathology has asked the US Supreme Court to consider whether isolated DNA sequences are patentable under US law
The Federal Circuit in September denied AMP’s request for a rehearing en banc of its case against Myriad Genetics. After that decision, an appeal to the country’s highest court was widely expected
Last week’s petition asks the High Court to consider two questions: 1) Are human genes patentable?; and 2)...
Only subscribers have complete access to Managing IP,
log in or
subscribe now.
Alternatively take a
free trial, giving you seven days access to Managing IP and regular newsletters for the international IP community, and US and Canadian practitioners specifically.
Subscribe Now
This article is available to subscribers. Please click subscribe to read the rest of the article.
Subscribe
Take a free trial
Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.
Take a free trial